Upcoming IPOs June 2026
So June 2026 is turning out to be quite an interesting month for the Indian IPO market. After a few weeks of relative quiet, things are finally picking up — and if you’ve been sitting on your Demat account wondering whether now is a good time to jump in, this post is for you.
Let me break everything down — the full IPO list, the GMP numbers, and my honest take on what’s worth your time and money.
Why June 2026 Is a Big Month for Upcoming IPOs
The market had been cautious for a while — global uncertainty, FII outflows, crude oil jitters. Companies were sitting on approved DRHPs but holding back. Then, in the first week of June alone, SEBI cleared five new IPOs worth nearly ₹10,000 crore in total. That’s a serious signal that confidence is returning to the primary market.
On top of that, some big names — OYO’s parent company PRISM, Truhome Finance, and others — finally got regulatory clearance after long delays. The floodgates are opening, and retail investors need to be prepared.
June 2026 IPO Full List (Mainboard + SME)
Here’s a clean, updated look at everything that opened, is open, or is coming up this month:
Mainboard IPOs
| Company | Open/Close | Price Band | Issue Size | Listing Date |
|---|---|---|---|---|
| CMR Green Technologies | June 3–5 | ₹182–₹192 | ₹630.88 Cr | June 10, 2026 |
| Hexagon Nutrition | June 5–9 | ₹42–₹45 | ₹139 Cr | June 11, 2026 |
SME IPOs (BSE SME / NSE Emerge)
| Company | Open/Close | Price Band | Listing Date |
|---|---|---|---|
| Merritronix | June 1–3 | ₹149 | June 8 (Listed) |
| GenXAI Analytics | June 5–9 | ₹116 | June 12, 2026 |
| UHM Vacation | June 4–8 | ₹166 | June 11, 2026 |
| Vahh Chemicals | June 4–8 | ₹60 | June 11, 2026 |
| Utkal Speciality Industries | June 10–12 | ₹62–₹66 | June 17, 2026 |
| Susan Electricals India | June 10–12 | TBA | TBA |
| Horizon Reclaim | June 10–12 | TBA | TBA |
Upcoming / SEBI-Approved (Expected Later in June / Q2 FY27)
- OYO (PRISM) — ₹6,650 Cr | SEBI approved June 2026
- Truhome Finance — ₹3,000 Cr | SEBI approved
- Advanta Enterprises — SEBI cleared
- Veegaland Developers — SEBI cleared
- Paras Healthcare — ₹1,800 Cr DRHP filed
- Kuku Technologies — ₹3,500 Cr confidential DRHP
- NSE IPO — Draft papers likely by second week of June
Latest IPO GMP Today (as of June 8, 2026)
GMP, or Grey Market Premium, is basically what people are willing to pay for shares before they even list officially. It’s unofficial, it’s not always right, but it gives you a decent pulse of market sentiment. Here’s where things stand today:
| IPO | Issue Price | GMP | Expected Listing Premium |
|---|---|---|---|
| CMR Green Technologies | ₹192 | ₹70 | 36–37% |
| Merritronix | ₹149 | ₹69 | 46% |
| Hexagon Nutrition | ₹45 | ₹12 | 26–27% |
| UHM Vacation | ₹166 | ₹34 | 20.5% |
| Vahh Chemicals | ₹60 | ₹13.5 | 22.5% |
| GenXAI Analytics | ₹116 | ₹10 | 8.6% |
Quick note on GMP: These numbers move every single day. A GMP of 37% today doesn’t guarantee a 37% gain on listing day. I’ve seen IPOs with sky-high GMPs list flat, and I’ve seen “boring” GMPs turn into surprise gainers. Use it as one data point, not the only data point.
Should You Apply? My Honest Take on Each
CMR Green Technologies — Apply (Strong)
This one already closed, but if you applied — good call. The GMP hit nearly 37–38%, the IPO was oversubscribed by a jaw-dropping 127x on the last day. Anchor investors included Goldman Sachs, BNP Paribas, and Citigroup — names that don’t show up for average companies. The company is a non-ferrous metal recycler serving Maruti, Bajaj, Hero, Honda, and Royal Enfield. Revenue grew from ₹5,968 Cr to ₹6,696 Cr in FY25, and the company swung from a massive ₹838 Cr loss to a ₹155 Cr profit. The only concern? It’s entirely an OFS — no fresh money for business growth. But the fundamentals are real.
Listing day expected to be strong — June 10, 2026.
Hexagon Nutrition — Apply With Caution
Pure-play nutrition company, priced between ₹42–₹45. Issue size is ₹139 Cr. The GMP has been a decent 26–27%, which is encouraging — but again, it’s a full OFS, meaning existing investors are cashing out, not the company raising capital for growth.
The nutrition sector is genuinely growing in India, but you need to look closely at whether Hexagon’s brand recall and distribution can hold up long-term. If you’re applying, apply for listing gains rather than long-term holding unless you study the financials deeply.
GenXAI Analytics — Watch & Decide
The GMP is modest at around 8–9%. Subscription data showed 56% subscription heading into the final day, which is lukewarm by current standards. It’s an NSE Emerge SME — smaller risk exposure, but also smaller upside. The company is in the AI analytics space, which is exciting, but the name and the sector alone don’t make a stock a winner. Check the DRHP financials before you decide.
Utkal Speciality Industries — Small Bet Possible
Paper-based products and packaging materials company. Issue size is just ₹34.5 Cr — tiny. Price band: ₹62–₹66. The company doubled its profit from ₹3.24 Cr to ₹6.68 Cr between FY24 and FY25 — that’s good growth momentum. At a sub-₹35 Cr issue size, allotment chances might actually be decent. Not a life-changing bet, but a reasonable small-cap SME play.
OYO (PRISM) — Watch But Don’t Chase
OYO finally got SEBI clearance in June 2026 for its ₹6,650 Cr IPO — after failing to list three times since 2021. The company has reportedly turned profitable for two consecutive years now, and the hotel/travel market recovery is real. But OYO’s history is complicated. SoftBank had blocked the filing as recently as mid-2025 over valuation disagreements.
This one will get huge media attention when it actually opens. Don’t let the noise make the decision for you — when the RHP drops, read the actual numbers. The valuation they’re targeting ($7–8 billion) will be the key test.
A Few Things Every IPO Investor Should Remember
Look, the IPO market can feel exciting — and it genuinely is. But here are a few things I think get forgotten in the hype:
OFS doesn’t mean bad, but understand what it means. When an IPO is entirely an Offer for Sale, the company itself gets zero rupees from the offering. That money goes to the sellers. The company isn’t “growing” from your investment in that specific fundraise. This doesn’t automatically make it a bad IPO — CMR Green is proof of that — but it changes the story.
127x oversubscription sounds incredible — but it also means your allotment chances were nearly zero. If you applied for CMR Green as a retail investor, chances are you either got one lot or nothing. Don’t fall into the trap of chasing listing day prices because you missed the IPO window.
GMP is not a guarantee. It is a mood. Treat it like that.
Long-term vs. listing gains — know your goal. If you’re applying just to sell on day one, that’s a valid strategy. But if you want a real investment, read the balance sheet, not just the GMP tracker.
Final Word
June 2026 is shaping up to be one of the busier IPO months of the year — with CMR Green and Hexagon Nutrition already wrapped up, a clutch of SME listings hitting the board, and some genuinely large names like OYO in the pipeline. The market mood has improved, and the SEBI pipeline is full.
If you’re an active IPO investor, this month deserves your attention. If you’re newer to this, CMR Green’s listing on June 10 will be an interesting case study to watch — even if you didn’t apply.
Stay updated, stay rational, and don’t let IPO FOMO override your research.